Your browser doesn't support javascript.
loading
Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical Trial.
Banerjee, Susana; Giannone, Gaia; Clamp, Andrew R; Ennis, Darren P; Glasspool, Rosalind M; Herbertson, Rebecca; Krell, Jonathan; Riisnaes, Ruth; Mirza, Hasan B; Cheng, Zhao; McDermott, Jacqueline; Green, Clare; Kristeleit, Rebecca S; George, Angela; Gourley, Charlie; Lewsley, Liz-Anne; Rai, Debbie; Banerji, Udai; Hinsley, Samantha; McNeish, Iain A.
Afiliación
  • Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Giannone G; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom.
  • Clamp AR; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom.
  • Ennis DP; The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom.
  • Glasspool RM; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom.
  • Herbertson R; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Krell J; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, United Kingdom.
  • Riisnaes R; Medical Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Mirza HB; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom.
  • Cheng Z; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom.
  • McDermott J; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom.
  • Green C; Department of Histopathology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Kristeleit RS; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • George A; Research Department of Oncology, UCL Cancer Institute, University College London, London, United Kingdom.
  • Gourley C; Now with Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Lewsley LA; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Rai D; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, United Kingdom.
  • Banerji U; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Hinsley S; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • McNeish IA; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom.
JAMA Oncol ; 9(5): 675-682, 2023 05 01.
Article en En | MEDLINE | ID: mdl-36928279
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Paclitaxel Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Paclitaxel Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido